DOCM — DocMorris AG Share News
0.000.00%
Last trade - 00:00- CH₣355.48m
- CH₣493.07m
- CH₣1.12bn
Europe Research Roundup: Barclays, Societe Generale, UBS Group
Brief: Shareholder CEPD Says It Rejects DocMorris' Mischaracterisation And Emphasizes Case For Real Governance Reform
DocMorris rises on 'strong' Q1 results
Brief: Docmorris Says Qtrly Revenue Rose By 11.7 Per Cent To CHF 303.8 Million
Brief: CEPD N.V Proposes To AGM Of DocMorris Major Renewal Of Board Of Directors
Brief: Docmorris Reaffirms EBITDA Breakeven In 2026
Swiss stocks - Factors to watch on March 19
Swiss stocks - Factors to watch on February 3
Brief: Docmorris Redeems Convertible Bonds Due 2026
Brief: DocMorris Repurchases Convertible Bonds Maturing In 2026 Worth Around Chf 14.4 Mln
Swiss stocks - Factors to watch on January 27
Swiss online pharmacy DocMorris 2025 revenue meets growth targets
Brief: Docmorris Confirms EBITDA Breakeven In Course Of 2026 And Free Cash Flow Breakeven In Course Of 2027
Swiss stocks - Factors to watch on November 14
Swiss stocks - Factors to watch on October 29
Brief: Docmorris AG Convertible And Delta Placing Final Delta Size Was C. 1.2m Shs / C. CHF 6.6m, Says Bookrunner
Brief: Bookrunner Says DocMorris AG Delta Placing Orders Below CHF 5.45 Per Share Risk Missing
Brief: Docmorris Launches Approx. CHF 45 Mln Convertible Bonds
Brief: Docmorris AG - Docmorris Increased Its External Revenue By 9.5 Per Cent To CHF 854.3 Million In First Nine Months 2025